IPO ETFs: The Low-Risk Way To Get In On Next Year’s Hot Tech IPOs

2016-10-23 09_28_05-Morguefile free photographs for commercial useToday’s article notes that “after a slow start to the year, global technology IPOs made a smashing comeback last month…making it the most active September for tech IPOs since the tech bubble era.” Moreover, 2017 is expected to see a “very robust” IPO market – including some high profile offerings such as Snapchat. For investors seeking a low-risk way to gain IPO exposure, the author recommends IPO-focused exchange-traded funds and highlights two such funds. To read about these two ETFs – including the different approaches they take to their respective holdings and which one has been the clear winner in terms of performance – CLICK HERE.

Dividend Paying & Share Count Reducing: A Winning Combination?

2016-09-06 19_17_19-Morguefile free photographs for commercial useBased on data from the end of 1985 on, a team of analysts from Jefferies have found that companies that paid dividends had higher average annual returns than non-payers, companies that reduced their share counts by repurchasing shares had higher average annual returns than those that let their share counts rise or remain the same, and companies that did both – paying dividends and reducing their share counts through buybacks – “outperformed the overall U.S. stock market significantly.” Given this, Jefferies has identified 17 stocks of companies it rates as “buy” that have been both paying dividends and reducing their share counts. To see what these stocks are, as well as their implied 12-month upside potential, CLICK HERE to read today’s article.

Meet The Little-Known Orthopedic-Device Stock Outperforming Johnson & Johnson

2016-09-04 15_47_00-Morguefile.com free stock photosThe stock highlighted in today’s article may not be anywhere near as well-known as its large, diversified rivals, but it is outperforming all of them – and, as such, it may be worth getting to know! The stock in question is Exactech, an orthopedic-device stock that “is the best-performing stock in the orthopedic products sector this year”, beating giants such as Johnson & Johnson and Smith & Nephew. (Exactech has gained 53% so far this year; its rivals have only gained an average of 14%). How has Exactech achieved these gains with little exposure and limited resources, and how is it positioned to continue this momentum going forward? CLICK HERE to find out.

Is China’s Rebound Sustainable? And How Can Investors Play It?

2016-08-01 07_36_37-Morguefile.com free stock photosIs China – which today’s article points out was “one of the least-loved stock markets in the world” earlier this year – now a buy? The author’s analysis is that the Chinese government has the ability to maintain its current stimulus spending – and thus boost employment, economic growth and the stock market – for years to come, and recommends that U.S.-based investors seek exposure to China’s growth through ETFs or stocks of Chinese companies traded on U.S. exchanges. To read more, including one specific ETF recommendation and five specific stock recommendations, CLICK HERE.

3 Cybersecurity Stocks To Consider Securing

2016-05-15 20_53_20-Morguefile.com free stock photosCyberspace is a dangerous world, but someone has to make money off it! In light of the fact that “driven by federal government initiatives, legislation and high-profile data breaches, cybersecurity spending will grow from $75 billion globally in 2015 to more than $100 billion by 2018”, today’s article highlights three cybersecurity stocks – “each disrupting niches within cybersecurity, data protection and network analysis” – to consider securing. To see what these three stocks are, as well as the author’s analysis of each – CLICK HERE.

Stocks For 2016

Have you started thinking about stocks for next year? Today’s article highlights 12 you may want to look into. This is what they found, “Here are the 12 buy-rated tech stocks that also have the highest growth rates via their revenue, cash flow and earnings in the S&P 500 Index, according to TheStreet Ratings, TheStreet’s proprietary ratings tool. TheStreet included trailing 12-month revenue growth, net income growth and earnings-per-share growth on each company for comparison.” To check out the stocks and to read more, CLICK HERE.

Stocks With Less Than Stellar Performances

Thumbs DownToday’s article discusses five stocks that haven’t been doing well for over six years. Will it surprise you that many of them are in the energy sector? Here’s what they had to say, “The S&P 500 has tripled in value since bottoming in March of 2009. But not every stock has gone along for the ride. In fact, some names have moved spectacularly in the wrong direction.” To check out which stocks they’re talking about and to read more, CLICK HERE.

Eyeing A Stock You Wish You Owned?

StarbucksAlways wanted to invest in a stock but were too afraid to take the leap? Today’s article explains how the author went through the same ordeal with Starbucks and then finally bought it. Here’s what they had to say, “With its forward P/E of 30.8, Starbucks could scare off investors as being too rich. The price reflects market optimism and a rosy growth outlook. From new store concepts in the works meant to boost after-hours traffic, including ‘Starbucks Evenings’, to plans for further expansion to approximately 30,000 locations (currently at around 22,000) there is more to come for this valuable brand.” To read more, CLICK HERE.

Will The Decision Make A Difference?

Finance conceptToday’s article discusses how Fed’s decision on rates may or may not affect investors. Here’s what they had to say, “Many investors are looking beyond Thursday, when the Fed may for the first time in nearly a decade raise the short-term benchmark interest rate. Regardless of the central bank’s decision, many investors expect anemic global growth will keep rates subdued in the long term.” To read more, CLICK HERE.

Up, up, up…down, down, down

Today’s article discusses the roller coaster ride the stock market was on today. What happened today? Here’s what they had to say, “U.S. stocks initially jumped Tuesday but the Dow, S&P 500 and Nasdaq all faltered as Wall Street sought to rebound from some from Monday’s 588-point drop in the Dow in a stock market rout that sent all the major indexes into official correction territory. Blue chips comprising the Dow took a huge swing, giving up a 442-point gain to end 205 in the red.” To read more, CLICK HERE.